Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 266

Similar articles for PubMed (Select 22507931)

1.

Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues.

Kumar A, Kumar AM, Gupta D, Kanchar A, Mohammed S, Srinath S, Tripathy S, Rajasekaran S, Chan PL, Swaminathan S, Dewan PK.

Int J Tuberc Lung Dis. 2012 May;16(5):573-8. doi: 10.5588/ijtld.11.0482.

PMID:
22507931
3.

HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. Review.

4.

Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment.

Bliven-Sizemore EE, Johnson JL, Goldberg S, Burman WJ, Villarino ME, Chaisson RE; Tuberculosis Clinical Trials Consortium.

Int J Tuberc Lung Dis. 2012 Apr;16(4):473-9. doi: 10.5588/ijtld.11.0548.

PMID:
22325844
5.

Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.

Raizada N, Chauhan LS, Babu BS, Thakur R, Khera A, Wares DF, Sahu S, Bachani D, Rewari BB, Dewan PK.

PLoS One. 2009 Jun 22;4(6):e5999. doi: 10.1371/journal.pone.0005999.

6.

Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.

Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, Ponnuraja C, Dilip M.

Natl Med J India. 2008 Jan-Feb;21(1):3-8.

PMID:
18472696
7.

Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study.

Vashishtha R, Mohan K, Singh B, Devarapu SK, Sreenivas V, Ranjan S, Gupta D, Sinha S, Sharma SK.

BMC Infect Dis. 2013 Oct 7;13:468. doi: 10.1186/1471-2334-13-468.

8.

Will adoption of the 2010 WHO ART guidelines for HIV-infected TB patients increase the demand for ART services in India?

Kumar AM, Gupta D, Rewari BB, Bachani D, Mohammed S, Sharma V, Lal K, Reddy HR, Naik B, Prasad R, Yaqoob M, Deepak KG, Shastri S, Satyanarayana S, Harries AD, Chauhan LS, Dewan P.

PLoS One. 2011;6(9):e24297. doi: 10.1371/journal.pone.0024297. Epub 2011 Sep 8.

9.

Diagnostic and management challenges for childhood tuberculosis in the era of HIV.

Marais BJ, Graham SM, Cotton MF, Beyers N.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S76-85. Review.

10.

Characteristics and programme-defined treatment outcomes among childhood tuberculosis (TB) patients under the national TB programme in Delhi.

Satyanarayana S, Shivashankar R, Vashist RP, Chauhan LS, Chadha SS, Dewan PK, Wares F, Sahu S, Singh V, Wilson NC, Harries AD.

PLoS One. 2010 Oct 12;5(10):e13338. doi: 10.1371/journal.pone.0013338.

11.

HIV and tuberculosis in India.

Swaminathan S, Nagendran G.

J Biosci. 2008 Nov;33(4):527-37. Review.

12.

Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.

Tripathy S, Anand A, Inamdar V, Manoj MM, Khillare KM, Datye AS, Iyer R, Kanoj DM, Thakar M, Kale V, Pereira M, Risbud AR.

Indian J Med Res. 2011 May;133:521-8.

13.

Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.

Manosuthi W, Tantanathip P, Chimsuntorn S, Eampokarap B, Thongyen S, Nilkamhang S, Sungkanuparph S.

Int J Infect Dis. 2010 Nov;14(11):e1013-7. doi: 10.1016/j.ijid.2010.06.016. Epub 2010 Sep 28.

14.

Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?

Zachariah R, Teck R, Ascurra O, Gomani P, Manzi M, Humblet P, Nunn P, Salaniponi FM, Harries AD.

Int J Tuberc Lung Dis. 2005 Mar;9(3):238-47. Review.

PMID:
15786885
15.

Therapeutic review: tuberculosis.

Houston S, Pozniak A, Ray CS.

Cent Afr J Med. 1991 Aug;37(8):250-9. Review.

PMID:
1807799
16.

Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.

Harries AD, Zachariah R, Chimzizi R, Salaniponi F, Gausi F, Kanyerere H, Schouten EJ, Jahn A, Makombe SD, Chimbwandira FM, Mpunga J.

BMC Public Health. 2011 Jul 27;11:593. doi: 10.1186/1471-2458-11-593.

17.

Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.

Lawn SD, Ayles H, Egwaga S, Williams B, Mukadi YD, Santos Filho ED, Godfrey-Faussett P, Granich RM, Harries AD.

Int J Tuberc Lung Dis. 2011 Mar;15(3):287-95.

PMID:
21333094
18.

HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.

Palacios E, Franke M, Muñoz M, Hurtado R, Dallman R, Chalco K, Guerra D, Mestanza L, Llaro K, Bonilla C, Sebastian J, Bayona J, Lygizos M, Anger H, Shin S.

Int J Tuberc Lung Dis. 2012;16(3):348-54. doi: 10.5588/ijtld.11.0473. Erratum in: Int J Tuberc Lung Dis. 2012 Apr;16(4):568. Lyzigos, M [corrected to Lygizos, M].

PMID:
22640448
19.

Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.

Banu Rekha VV, Balasubramanian R, Swaminathan S, Ramachandran R, Rahman F, Sundaram V, Thyagarajan K, Selvakumar N, Adhilakshmi AR, Iliayas S, Narayanan PR.

Indian J Med Res. 2007 Nov;126(5):452-8.

PMID:
18160750
20.

Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.

Regazzi M, Carvalho AC, Villani P, Matteelli A.

Clin Pharmacokinet. 2014 Jun;53(6):489-507. doi: 10.1007/s40262-014-0144-3. Review.

PMID:
24777631
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk